| 產(chǎn)品名稱 |
NCI-H524 [H524] |
| 商品貨號 |
B165351 |
| Organism |
Homo sapiens, human |
| Tissue |
lung; derived from metastatic site: lymph node |
| Product Format |
frozen |
| Culture Properties |
suspension |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease |
stage L,carcinoma; variant small cell lung cancer |
| Age |
63 years |
| Gender |
male |
| Ethnicity |
Caucasian |
| Derivation |
The line was established in November 1982. |
| Clinical Data |
63 years
Caucasian
male
The patient received prior chemotherapy and radiation therapy.
The patient was a smoker. |
| Complete Growth Medium |
The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
|
| Cryopreservation |
Culture medium, 95%; DMSO, 5% |
| Culture Conditions |
Temperature: 37°C |
| STR Profile |
Amelogenin: X CSF1PO: 12 D13S317: 12 D16S539: 12 D5S818: 12 D7S820: 11,12 THO1: 8,9.3 TPOX: 8,10 vWA: 14,17 |
| Name of Depositor |
AF Gazdar, JD Minna |
| Deposited As |
Homo sapiens |
| Year of Origin |
1982 |
| References |
NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.
|
